Genetic risk for chronic fatigue syndrome

Bidragets beskrivning

The goal of this proposal is to understand underlying biological mechanisms behind chronic fatigue syndrome (CFS) and long-term symptoms from COVID-19 (LongCOVID) using genetics and epidemiology. A hallmark of CFS is debilitating fatigue, migrating pain, headache, fluctuating heart rate and dysautonomia. CFS diagnosis can follow infections or self-reported infection, and flu-like symptoms. Similarly, a characteristic in infection with SARS-CoV-2 is that some individuals with relatively mild infection develop long-term symptoms of severe fatigue, pain and dysautonomia similar to CFS. Currently, there is no cure and the treatment options are symptomatic. We will use genetic and epidemiology tools to explore the etiology of CFS and LongCOVID. The project has the potential to discover novel biological molecules, elucidate mechanisms from infections and autoimmunity on CFS and explore the disease burden from CFS and LongCOVID at the population level.
Visa mer

Startår

2022

Slutår

2027

Beviljade finansiering

Hanna Ollila Orcid -palvelun logo
447 650 €

Andra beslut

372129
Akademiforskarens forskningskostnader(2025)
181 775 €
353812
Akademiforskarens forskningskostnader(2022)
300 000 €

Finansiär

Finlands Akademi

Typ av finansiering

Akademiforskare

Beslutfattare

Forskningsrådet för biovetenskap, hälsa och miljö
30.05.2022

Övriga uppgifter

Finansieringsbeslutets nummer

350181

Vetenskapsområden

Genetik, utvecklingsbiologi, fysiologi

Forskningsområden

Perinnöllisyystiede

Identifierade teman

public health, occupational health